Ontology highlight
ABSTRACT:
SUBMITTER: Barone E
PROVIDER: S-EPMC5830549 | biostudies-literature | 2018 Jan
REPOSITORIES: biostudies-literature
Journal of thoracic disease 20180101 Suppl 2
Malignant pleural mesothelioma (MPM) is a very aggressive cancer poorly responsive to current therapies. MPM patients have a very poor prognosis with a median survival of less than one year from the onset of symptoms. The biomarkers proposed so far do not lead to a sufficiently early diagnosis for a radical treatment of the disease. Thus, the finding of novel diagnostic and prognostic biomarkers and therapeutic targets is needed. Gene overexpression has been frequently associated with a malignan ...[more]